Thailand is poised to take the promising field of stem cell technology further. Thailand will be the champions of a pioneering study that intends to verify the virtue, success and safety of stem cell technology in providing a cure for heart disease.
Experiments will be conducted on humans, and will target 40 heart patients. This study will be a fusion of efforts from the Department of Medical Sciences, Mahidol University and the Cardiac Institute of Thailand.
AdvertisementThe test will be completed in a 2 month time frame. Despite the completion of the experiment in 2 months, yet it will take the teams at least a year to conclusively prove the benefits of stem cell treatment on heart patients, due to the necessity of thorough follow up with the patients in the experiment.
Pakdee Pothisiri, secretary-general of the Food and Drug Administration (FDA), has confirmed the department's efforts in drawing a legal framework that can lay emphasis on strict control and safety in the imports and exports of stem cells.
The study on the efficacy of stem cells, will a go a long way in not only providing succor for people suffering from heart disease but will also serve as regenerative medicine for other diseases such as diabetes and brain disorders.
You May Also Like